GLP1R and type 2 diabetes mellitus: In their vanguard study, Meier and colleagues randomised eight patients with T2DM who had undergone major surgery within the preceding week to 8-h infusions of intravenous GLP-1 (1.2 pmol kg− 1 min− 1) and placebo in a cross-over fashion [29].